Prof. Dr. Cumali Aktolun

Nükleer Tıp · Daha fazla uzmanliklar hakkinda

Ankara 1 adres

İletişim Bilgileri

Özgeçmiş

Prof Dr Cumali Aktolun Kimdir?

GATA Tıp Fakültesini 1985 yılında bitirdikten sonra 1990 yılında Ankara GATA Eğitim Araştırma Hastanesinde Nükleer Tıp uzmanlık eğitimini, 1993 yılında University of London’da Nükleer Tıp Yüksek Lisansı eğitimini, 1994 yılında İngiltere Imperial College (Royal Postgraduate Medical School) bünyesindeki Hammersmith Hastanesinde Clinical Fellowship eğitimini tamamlamıştır. 1995 yılında Doçent, 2001'de profesör olmuştur. 1996-2002 yılları arasında Kocaeli Üniversitesi Tıp Fakültesinde Nükleer Tıp Ana Bilim Dalının kurucu başkanlığını yapmıştır. 2012-2013 öğretim yılında A.B.D.’de Stanford University School of Medicine’de kadrolu Visiting Professor olarak çalışmış, 2003-2016 yılları arasında İstanbul’da Tirocenter Tiroid Merkezinde sürdürdüğü özel hekimliği takiben 2016 yılında Kanada’da University of Manitoba School of Medicine’de kadrolu full professor ve klinik hekim olarak çalışmış, 2018-2019 yılları arasında henüz kuruluş aşamasındaki İzmir Ekonomi Üniversitesi Tıp Fakültesi Nükleer Tıp Anabilim Dalında, 2021-2025 yılları arasında Alanya Alaaddin Keykubat Üniversitesi Nükleer Tıp Anabilim Dalında  profesör kadrosunda görev almıştır. Prof.Dr Cumali Aktolun’un A.B.D.’de yayınlanmış ve halen güncel olan 5 adet İngilizce kitabı mevcut olup Avrupa Nükleer Tıp Birliği adına yayınlanan 9 adet uygulama rehberini hazırlayan ekibin içinde yer almıştır. Avrupa Nükleer Tıp Birliği EANM Tiroid Komitesi kurucu başkan yardımcısı olarak görev yapmıştır. 41 yıllık klinik hekimlik deneyimi ve Nükleer Tıp tanı tedavi uygulamaları alanındaki bilgi ve tecrübe birikimi içerisinde; uluslararası düzeyde tanınan ve kabul edilen tiroid kanseri, prostat kanseri, nöroendokrin tümörler, Nükleer Tıp Tedavi teknikleri ve PET/BT konularında özel uzmanlık bilgi ve tecrübesine (special expertise) sahiptir.

daha fazla Hakkımda

Hakkımda

Prof Dr Cumali Aktolun Kimdir?

GATA Tıp Fakültesini 1985 yılında bitirdikten sonra 1990 yılında Ankara GATA Eğitim Araştırma Hastanesinde Nükleer Tıp uzmanlık eğitimini, 1993 yılında University of London’da Nükleer Tıp Yüksek Lisansı eğitimini, 1994 yılında İngiltere Imperial College (Royal Postgraduate Medical School) bünyesindeki Hammersmith Hastanesinde Clinical Fellowship eğitimini tamamlamıştır. 1995 yılında Doçent, 2001'de profesör olmuştur. 1996-2002 yılları arasında Kocaeli Üniversitesi Tıp Fakültesinde Nükleer Tıp Ana Bilim Dalının kurucu başkanlığını yapmıştır. 2012-2013 öğretim yılında A.B.D.’de Stanford University School of Medicine’de kadrolu Visiting Professor olarak çalışmış, 2003-2016 yılları arasında İstanbul’da Tirocenter Tiroid Merkezinde sürdürdüğü özel hekimliği takiben 2016 yılında Kanada’da University of Manitoba School of Medicine’de kadrolu full professor ve klinik hekim olarak çalışmış, 2018-2019 yılları arasında henüz kuruluş aşamasındaki İzmir Ekonomi Üniversitesi Tıp Fakültesi Nükleer Tıp Anabilim Dalında, 2021-2025 yılları arasında Alanya Alaaddin Keykubat Üniversitesi Nükleer Tıp Anabilim Dalında  profesör kadrosunda görev almıştır. Prof.Dr Cumali Aktolun’un A.B.D.’de yayınlanmış ve halen güncel olan 5 adet İngilizce kitabı mevcut olup Avrupa Nükleer Tıp Birliği adına yayınlanan 9 adet uygulama rehberini hazırlayan ekibin içinde yer almıştır. Avrupa Nükleer Tıp Birliği EANM Tiroid Komitesi kurucu başkan yardımcısı olarak görev yapmıştır. 41 yıllık klinik hekimlik deneyimi ve Nükleer Tıp tanı tedavi uygulamaları alanındaki bilgi ve tecrübe birikimi içerisinde; uluslararası düzeyde tanınan ve kabul edilen tiroid kanseri, prostat kanseri, nöroendokrin tümörler, Nükleer Tıp Tedavi teknikleri ve PET/BT konularında özel uzmanlık bilgi ve tecrübesine (special expertise) sahiptir.

Başlıca İlgi Alanları

Görülen hasta/danışanlar

Yetişkin

Özgeçmiş

Doctor
Cumali Aktolun

Nükleer Tıp

Uzmanlık alanları

  • Nükleer tıp

Deneyimler

  • Kocaeli Üniversitesi Tıp Fakültesi - Anabilimdalı Başkanı, 1996-2002
  • Stanford University MIPS Program, 2012-2013
  • Alanya Alaaddin Keykubat Üniversitesi Tıp Fakültesi-AnaBilim Dalı Başkanı 2021-2025
  • Tirocenter Nükleer Tıp ve Tiroit Merkezi Sorumlu Hekimi, 2002-2012
  • Hammersmith Hospital-Clinical Fellow, 1991-1995
  • GATA Nükleer Tıp Anabilim Dalı-Uzmanlık, 1987-1991
  • İzmir Ekonomi Üniversitesi Tıp Fakültesi, 2018-2020
Tümünü göster

Okullar / eğitimler

  • Kuleli Askeri Lisesi, 1975-1979
  • Gazi Üniversitesi Tıp Fakültesi, 1979-1980
  • Gülhane Askeri Tıp Fakültesi, 1980-1985
  • University of London-Yüksek Lisans, 1991-1993
  • Gülhane Askeri Tıp Akademisi Hastanesi-Nükleer Tıp İhtisası, 1987-1991
Tümünü göster

İlgi alanları

Tümünü göster

Yayınlar

  • Uluslararası Bilimsel Dergilerde Yayınlanmış Başyazılar (Editorials published in international journals) Toplam 5 adet Başyazı (Editorial) yayınlamıştır. 1-‘’Artificial intelligence and radiomics in nuclear medicine: potentials and challenges’’. Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2731-2736. doi: 10.1007/s00259-019-04593-0. 2-‘’The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine’’. Eur J Nucl Med Mol Imaging. 2016; 43: 1486-90. 3-‘’Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer’’. Eur J Nucl Med Mol Imaging. 2016; 43: 1001-5. 4-‘’Theranostic role of MIBG in neuroblastoma’’. Q J Nucl Med Mol Imaging. 2013; 57: 3-5. 5-‘’Diagnostic and therapeutic use of MIBG in pheochromocytoma and paraganglioma’’. Q J Nucl Med Mol Imaging. 2013; 57: 109-11. Avrupa Nükleer Tıp Birliği EANM İngilizce Klinik Uygulama Rehberleri (European Association of Nuclear Medicine EANM Procedure Guidelines) Toplam 9 adet Klinik Uygulama Rehberi (Procedure Guidelines) yayınlamıştır. 1) EANM Guidelines for Radionuclide therapy of bone metastases with beta-emitting radionuclides, 2018. 2) EANM Guidelines I-131/I-123 metaiodobenzyl guanidine (mIBG) scintigraphy, 2010. 3) EANM Guidelines In-111 pentetreotide scintigraphy, 2010. 4) EANM Guidelines Ga-67 scintigraphy, 2003. 5) EANM Guidelines In-111 pentetreotide scintigraphy, 2003. 6) EANM Guidelines F-18 FDG-PET in Tumor Imaging, 2003. 7) EANM Guidelines I-131/I-123 metaiodobenzylguanidine (MIBG) scintigraphy, 2003. 8) EANM Guidelines Breast scintigraphy, 2003. 9) EANM Guidelines Bone scintigraphy, 2003. Uluslararası Tıp Kitaplarında Yayınlanmış İngilizce Kitap Bölümleri (Book Chapters Published in Peer-Reviewed Books Published by International Publishers) 1. Aktolun C: ‘’Pulmonary Tumors’’ in Nuclear Oncology; Aktolun C, Newlon TW (Editors); Springer, Germany, pp. 103- 129, 1999. 2. Waxman AD, Aktolun C: ‘’Breast Cancer’’ in Nuclear Oncology; Aktolun, C, Tauxe NW (Editors); publisher: Springer, Germany, pp. 143-162, 1999. 3. Aktolun C, Urhan M: ‘’Radionuclide Therapy in Benign Thyroid Diseases’’ in Nuclear Medicine Therapy: Principles and Clinical Applications; Cumali Aktolun, Stanley Goldsmith (Editors), publisher: Springer, USA, pp. 281-314, 2013. 4. Aktolun C. ‘’Challenges Associated with Radionuclide Therapy and Need for Interdepartmental Collaboration’’ in Nuclear Medicine Therapy: Principles and Clinical Applications; Cumali Aktolun, Stanley Goldsmith (Editors), publisher: Springer, USA, pp. 425-430, 2013. 5. Aktolun C, Elboga U, Urhan M: “Thyroid Carcinoma’’ (Organ Malignancies) in Nuclear Oncology, Cumali Aktolun; Stanley J Goldsmith (Editors); publisher Lippincott Williams Wilkins, USA, pp. 35-51, 2015. 6. Aktolun C, Urhan M, Elboga U: “Breast carcinoma’’ (Organ Malignancies) in Nuclear Oncology. Cumali Aktolun, Stanley J Goldsmith (Editors); publisher Lippincott Williams Wilkins, USA, pp. 132-152, 2015. Türkçe Tıp Kitaplarında Yayınlanmış Kitap Bölümleri (Book Chapters Published in Turkish) 1. Berk F, Demir H, Aktolun C: ‘’Nükleer Kardiyoloji’’ başlıklı bölüm (Klinik Kardiyoloji isimli kitap içinde), Komsuoglu B (Editör), Nobel Kitapevleri, pp. 137-152, 2004. Hakemli Uluslararası Bilimsel Dergilerde Yayınlanmış İngilizce Makaleler. (Articles Published in Peer Reviewed International Journals) 1. Aktolun c. Artificial intelligence and radiomics in nuclear medicine: potentials and challenges. Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2731-2736. doi: 10.1007/s00259-019-04593-0. 2.Luster M, Aktolun C, Amendoeira I, Barczyński M, Bible KC, Duntas LH, Elisei R, Handkiewicz-Junak D, Hoffmann M, Jarzab B, Leenhardt L, Musholt TJ, Newbold K, Nixon IJ, Smit J, Sobrinho-Simões M, Sosa JA, Tuttle RM MD, Verburg F, Wartofsky L, Führer-Sakel D. European perspective on the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Proceedings of an interactive international symposium. Thyroid. 2018 Nov 28. doi: 10.1089/thy.2017.0129. 3. Handkiewicz-Junak D, Poeppel TD, Bodei L, Aktolun C, Ezziddin S, Giammarile F, Delgado-Bolton RC, Gabriel M. EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides. Eur J Nucl Med Mol Imaging. 2018 May;45(5):846-859. doi: 10.1007/s00259-018-3947-x. Epub 2018 Feb 16. 4.Treglia G, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Verburg FA, Luster M; EANM and the EANM Thyroid Committee. The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2016 Apr 27. Eur J Nucl Med Mol Imaging. 2016; 43: 1486-90. 5. Verburg FA, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Luster M; EANM and the EANM Thyroid Committee.Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2016; 43: 1001-5. 6. Elboga U, Kalender E, Çelen YZ, Yilmaz M, Aktolun C: Pulmonary arteriovenous malformation mimicking a pulmonary tumour on (18)F-fluorodeoxyglucose positron-emission tomography/computed tomography. Arch Med Sci. 2015; 11: 461-2. 7. Elboga U, Kervancioğlu S, Sahin E, Basibuyuk M, Celen YZ, Aktolun C. Utility of F-18 fluorodeoxyglucose positron emission tomography/computed in carcinoma of unknown primary. Int J Clin Exp Pathol. 2014; 7: 8941-6. 8. Aktolun C, Castellani MR, Bombardieri E. Diagnostic and therapeutic use of MIBG in pheochromocytoma and paraganglioma. Q J Nucl Med Mol Imaging. 2013; 57: 109-11. 9. Castellani MR, Aktolun C, Buzzoni R, Seregni E, Chiesa C, Maccauro M, Aliberti GL, Vellani C, Lorenzoni A, Bombardieri E. Iodine-131 metaiodobenzylguanidine (I-131 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: current problems, critical issues and presentation of a sample case. Q J Nucl Med Mol Imaging. 2013; 57: 146-52. 10. Lopci E, Zanoni L, Fanti S, Ambrosini V, Castellani MR, Aktolun C, Chiti A. Gallium-68 DOTANOC imaging in paraganglioma/pheochromocytoma: presentation of sample cases and review of the literature. Q J Nucl Med Mol Imaging. 2013; 57: 134-45. 11. Buzzoni R, Pusceddu S, Damato A, Meroni E, Aktolun C, Milione M, Mazzaferro V, De Braud F, Spreafico C, Maccauro M, Zaffaroni N, Castellani MR. Malignant pheochromocytoma and paraganglioma: future considerations for therapy. Q J Nucl Med Mol Imaging. 2013; 57: 153-60. 12. Aktolun C, Castellani MR: Theranostic role of MIBG in neuroblastoma. Q J Nucl Med Mol Imaging. 2013; 57: 3-5. 13. Elboga U, Kalender E, Celen YZ, Aktolun C. F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan imaging in sarcoidosis involving multiple lymph nodes, lung parenchyma, liver and skeleton. Indian J Nucl Med. 2012; 27: 134-6. 14. Umut Elboga, Ebuzer Kalender, Y.Zeki Çelen,M., Cumali Aktolun. Axillary lymph node metastasis of papillary thyroid carcinoma detected by FDG PET/CT in a thyroglobulin positive patient with negative whole body iodine-131 scan. Clin Nucl Med. 2012; 37: 1120-1122. 15. Bombardieri E, Giammarile F, Aktolun C, Baum RP, Bischof Delaloye A, Maffioli L, Moncayo R, Mortelmans L, Pepe G, Reske SN, Castellani MR, Chiti A. (131)I/ (123)I-Metaiodobenzyl guanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2010; 37: 2436-46. 16. Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-Delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A. Oncology Committee of the EANM. 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2010; 37: 1441-8. 17. Demir H, Berk F, Raderer M, Plowman PN, Lassen U, Daugaard G, Clausen M, Bohuslavizki KH, Peters M, Harmer C, Malamitsi J, Aktolun C. The role of nuclear medicine in the diagnosis of cancer of unknown origin. Q J Nucl Med Mol Imaging. 2004; 48: 164-73. 18. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP140-7. 19. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. 131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP132-9. 20. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. Ga-67 scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP125-31. 21. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. FDG-PET: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP115-24. 22. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. Breast scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP107-14. 23. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Morteímans L, Reske SN. Bone scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP99-106. 24. Berk F, Demir H, Aktolun C. Thallium-201 imaging in the assessment of tumor response to anti-tumor treatments. Q J Nucl Med. 2003; 47: 63-74. 25. Demir H, Erbay G, Kir KM, Omurlu K, Berk F, Aktolun C. Clinical validation of technetium-99m MIBI-gated single-photon emission computed tomography (SPECT) for avoiding false positive results in patients with left bundle-branch block: comparison with stress-rest nongated SPECT. Clin Cardiol. 2003; 26: 182-7. 26. Demir H, Berk F, Isgoren S, Erdincler RO, Ciftci E, Aktolun C. Subhyoid ectopic thyroid with mediolateral location in a developmentally retarded child with hypothyroidism in an iodine deficiency region. Ann Nucl Med. 2002; 16: 483-6. 27. Berk F, Demir H, Ağaçdiken A, Ural D, Aktolun C. Hypertrophied papillary muscles mimicking left ventricular mass on Tc-99m MIBI myocardial perfusion scintigraphy. J Nucl Cardiol. 2002; 9: 441-2. 28. Berk F, Demir H, Erdincler O, Isgoren S, Aktolun C. Tc-99m MDP and Tc-99m MIBI dual imaging of photopenic bone metastases of carcinoma of the larynx. Clin Nucl Med. 2002; 27: 442-3. 29. Demir H, Berk F, Memisoglu K, Arslan A, Muezzinoglu B, Erdincler RO, Isgoren S, Sarlak A, Aktolun C. "Double imaging" for the diagnostic work-up of alveolar soft part sarcoma with Tc-99m MIBI. Ann Nucl Med. 2002; 16: 151-5. 30. Berk F, Demir H, Hacihanefioglu A, Arslan A, Erdincler O, Isgoren S, Aktolun C. Hepatic and splenic uptake of Tc-99m HDP in multiple myeloma: additional findings on Tc-99m MIBI and Tc-99m sulfur colloid images. Ann Nucl Med. 2002; 16: 137-41. 31. Demir H, Berk F, Erdincler O, Isgoren S, Aktolun C. Tl-201 imaging in the diagnostic work-up of squamous cell carcinoma metastasis of unknown primary origin. Clin Nucl Med. 2002; 27: 385-6. 32. Berk F, Demir H, Erdincler O, Isgoren S, Aktolun C. Ga-67 accumulation in inguinal hernia mimicking lymph nodes in non-Hodgkin's lymphoma. Clin Nucl Med. 2002; 27: 65-6. 33. Aktolun C, Demir H, Berk F. Complete lingual ectopia of the thyroid in a hypothyroid child. Thyroid. 2001; 11: 1081. 34. Aktolun C, Berk F, Demir H, Ercin C. Tc-99m MIBI imaging in malignant fibrous histiocytoma. Ann Nucl Med. 2001; 15: 451-3. 35. Aktolun C, Demir H, Berk F, Metin Kir K. Diagnosis of complete ectopic lingual thyroid with Tc-99m pertechnetate scintigraphy. Clin Nucl Med. 2001; 26: 933-5. 36. Aktolun C, Berk F, Demir H. Detection of cold bone metastasis by Tc-99m MIBI imaging. Ann Nucl Med. 2001; 15: 393-5. 37. Ural D, Ural E, Kahraman G, Caymaz O, Aktolun C, Komsuolu B. Effect of the Valsalva manoeuver on diastolic filling indices in patients with essential hypertension. J Hum Hypertens. 2001; 15: 607-12. 38. Aktolun C. What is the best technique for patient positioning during breast scintigraphy? J Nucl Med. 1996; 37: 2098-100. 39. Aktolun C. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg. 1995; 181: 477-9. 40. Aktolun C, Bayhan H, Ozturk E. Better visualization of retinoblastoma metastases with Tc-99m sestamibi versus Tl-201. Clin Nucl Med. 1995; 20: 446-8. 41. Aktolun C, Ussov WY, Arka A, Glass D, Gunasekera RD, Peters AM. Technetium-99m and indium-111 double labelling of granulocytes for kinetic and clinical studies. Eur J Nucl Med. 1995; 22: 330-4. 42. Ussov WY, Aktolun C, Myers MJ, Jamar F, Peters AM. Granulocyte margination in bone marrow: comparison with margination in the spleen and liver. Scand J Clin Lab Invest. 1995; 55: 87-96. 43. Aktolun C. Technetium-99m-sestamibi imaging in breast cancer: an alternative to thallium-201 imaging. J Nucl Med. 1994; 35: 2055-6. 44. Aktolun C, Bayhan H. Tc-99m MIBI uptake in pulmonary sarcoidosis. Preliminary clinical results and comparison with Ga-67. Clin Nucl Med. 1994; 19: 1063-5. 45. Aktolun C. Exaggerated role of prone technique in breast cancer imaging with technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med. 1994; 21: 1257-60. 46. Aktolun C. Tc-99m sestamibi imaging is useful in brain metastases. Clin Nucl Med. 1994; 19: 1033-4. 47. Aktolun C. TBI is not MIBI. J Nucl Med. 1994; 35:1560-1. 48. Aktolun C, Bayhan H, Pabuccu Y, Bilgic H, Acar H, Koylu R. Assessment of tumour necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m sestamibi imaging: comparison with CT scan. Eur J Nucl Med. 1994; 21: 973-9. 49. Arka A, Aktolun C, Gooden C, Epenetos A, Papadimitriou A. Tc-99m-labeled nonspecific polyclonal human immunoglobulin G is taken up by malignant tumors. Clin Nucl Med. 1994; 19: 708-12. 50. Aktolun C. Misleading figure of focal activity in the liver. J Nucl Med. 1993; 34: 2276. 51. Aktolun C. 201-Tl as a tumour-localizing agent. Nucl Med Commun. 1993; 14: 1042-4. 52. Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201. Clin Nucl Med. 1992; 17: 171-6. 53. Aktolun C, Demirel D, Kir M, Bayhan H, Maden HA. Technetium-99m-MIBI and thallium-201 uptake in pulmonary actinomycosis. J Nucl Med. 1991; 32: 1429-31. 54. Aktolun C, Bayhan H. Detection of focal nodular hyperplasia with liver colloid single photon emission computed tomography: a case report and review of the literature. Br J Radiol. 1991; 64: 64-6. 55. Aktolun C, Bayhan H, Celasun B, Kir MK. Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease). Eur J Nucl Med. 1991; 18: 856-9. Hakemli Ulusal Bilimsel Dergilerde Yayınlanmış Türkçe Makaleler (Papers Published in Peer-Reviewed Turkish Journals) 1. Ural D, Ural E, Kahraman G, Sekban A, Caymaz O, Aktolun C, Komsuoğlu B. Esansiyel hipertansiyonlu hastalarda Valsalva manevrasının diyastolik doluş indekslerine etkisi. Türk Kardiyoloji Derneği Arşivi Dergisi, 2000; 28: 150-155. 2. Ural D, Ural E, Kahraman G, Ağaçdiken A, Vural A, Aktolun C, Komsuoğlu B. Miyokard perfüzyon sintigrafisinde iskemi saptanan normal koroner arterli hipertansif hastaların klinik, ekokardiyografik ve aritmojenik özellikleri. Türkiye Kardiyoloji Derneği Arşivi Dergisi, 2001; 29: 406-412. 3. Şahin T, Ural D, Berk F, Ural E, Ağaçdiken A, Kahraman G, Vural A, Özden M, Demir H, Aktolun C, Komsuoğlu B. Esansiyel hipertansiyonlu hastalarda sessiz miyokard iskemisi ile aort stenozu arasındaki ilişki. Türkiye Kardiyoloji Derneği Arşivi Dergisi, 2003; 31: 29-34. Hakemli Uluslararası Bilimsel Kongrelerde Sunulmuş İngilizce Kongre Sunumları (Papers Presented in International Congresses and Printed in Congress Abstract Books) 1. Elboga U, Orquiza M, Aktolun C, Van Nostrand D: The utility of ‘’blind’’ I-131 treatment for differentiated thyroid cancer (an educational exhibit), Society of Nuclear Medicine Annual Meeting, 2013. J Nucl Med 2013; 54 (suppl.2): 1290. 2. Elboğa U, Elboğa G, Başıbüyük M, Çelen YZ, Aktolun C. Assessment of health related quality of life in patients with thyroid carcinoma during thyroxin withdrawal periods. European Association of Nuclear Medicine (EANM) Annual Meeting, Milano, 2012. Eur J Nucl Med Mol Imaging 2012; 39: 10: S345. 3. Elboğa U, Elboğa G, Başıbüyük M, Çelen YZ, Aktolun C. Assessment of anxiety and depression in oncology patients undergoing F-18 FDG PET/CT imaging. European Association of Nuclear Medicine (EANM) Annual Meeting, Milano, 2012. Eur J Nucl Med Mol Imaging; 2012; 39: 10: S556. 4. Elboğa U, Yilmaz M, Uyar M, Celen YZ, Bakir K, Dikensoy O, Aktolun C. Role of F18-FDG PET/CT in differentiating malignant pleural lesions in an endemic asbestosis area: special emphasis on dual time point imaging. European Association of Nuclear Medicine (EANM) Annual Meeting, Milano, 2012. Eur J Nucl Med Mol Imaging 2012; 39: 10: S569. 5. Elboğa U, Kurt Z, Celen YZ, Aktolun C. Role of F-18 FDG PET/CT imaging in metastases of unknown primary. European Association of Nuclear Medicine (EANM) Annual Meeting, Milano, 2012. Eur J Nucl Med Mol Imaging 2012; 39: 10: S590. 6. Aktolun C, Girisken G, Bukey Y, Urhan M, Elboga U. Ga-68 DOTATAE and F18-FDG PET/CT in the diagnostic workup of a collision tumor of the thyroid gland. Canadian Association of Nuclear Medicine Annual Meeting and SNM East Great Lakes Chapter Meeting, 2-5 May 2012, Ottawa. Congress Abstract Book, 2012; p. 21. 7. Aktolun C, Girisken G, Bukey Y, Urhan M, Elboga U, Van Nostrand D. Iodine negative disseminated metastases of thyroid papillary carcinoma at the time of patient’s initial presentation: role of F-18 FDG PET/CT as the primary diagnostic tool. Canadian Association of Nuclear Medicine Annual Meeting and SNM East Great Lakes Chapter Meeting, 2-5 May 2012, Ottawa. Congress Abstract Book, 2012; pp. 21-22. 8. Elboğa U, Elboğa G, Başıbüyük M, Çelen YZ, Aktolun C. Assessment of health-related Quality of life, depression and anxiety in hypothyroid patients with thyroid carcinoma during thyroxin withdrawal. Canadian Association of Nuclear Medicine Annual Meeting and SNM East Great Lakes Chapter Meeting, 2-5 May 2012, Ottawa. Congress Abstract Book, 2012; p. 44. 9. Elboğa U, Kurt Z, Celen YZ, Aktolun C. 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Carcinoma of Unknown Primary: 6-Year Single Institution Experience. Canadian Association of Nuclear Medicine Annual Meeting and SNM East Great Lakes Chapter Meeting, 2-5 May 2012, Ottawa. Congress Abstract Book, 2012; p. 67. 10. Sahin T, Ural D, Berk F, Ural E, Kozdağ G, Kahraman G, Özden M, Aktolun C, Komsuoglu B: Relation of silent myocardial ischemia and aortic valve sclerosis in patients with essential hypertension. The European Society of Cardiology XXIII Congress 2001, Sweden. Eur Heart J 2001 23:106. 11. Demir H, Berk F, Erdincler O, Isgoren S, Aktolun C. Comparison of planar and SPECT Tc-99m DMSA scintigraphy for the detection of renal cortical defects in patients with urinary tract infections. European Association of Nuclear Medicine (EANM) Annual Meeting 2001, Italy. Eur J Nucl Med 2001; 28:1256. 12. Berk F, Koyun M, Demir H, Erdincler O, Isgoren S, Cetinarslan B, Aktolun C. Bone mineral metobolism during antithyroid therapy for endogeneous subclinical hyperthyroidism. European Association of Nuclear Medicine (EANM) Annual Meeting 2001, Italy. Eur J Nucl Med 2001; 28:1006. 13. Berk F, Sahin T, Demir H, Ural E, Erdincler O, Isgoren S, Komsuoglu B, Aktolun C. Tl-201 myocardial perfusion SPECT evaluation of silent coronary artery disease in patients with essential hypertension. European Association of Nuclear Medicine (EANM) Annual Meeting 2001, Italy Eur J Nucl Med 2001; 28: 963. 14. Aktolun C, Bayhan H, Pabuccu Y, Bilgic H, Acar H, Koylu R. Detection of mediastinal lymph node metastasis with Tc-99m sestamibi imaging: comparison to CT scan. European Association of Nuclear Medicine and World Federation of Nuclear Medicine Meeting, 1994, Australia. (Congress Highlights Lecture). Eur J Nucl 1994; 21(suppl): S76. 15. Aktolun C, Bayhan H, Pabuccu Y, Bilgic H, Acar H, Koylu R. Use of Tc-99m sestamibi for the assessment of tumor viability in bronchial carcinoma. European Association of Nuclear Medicine and World Federation of Nuclear Medicine Meeting, 1994, Australia. (Congress Highlights Lecture). Eur J Nucl 1994; 21(suppl): S116. 16. Aktolun C, Ussov WY, Arka A, Glass D, Gunasekara RD, Peters AM. Double labelling of granulocytes for the diagnosis of bone infection due to orthopedic implants: exploiting granulocyte margination in bone marrow. European Association of Nuclear Medicine and World Federation of Nuclear Medicine Meeting, 1994, Australia. (Congress Highlights Lecture). Eur J Nucl 1994; 21(suppl): S73. 17. Aktolun C, Bayhan H, Pabuccu Y, Bilgic H, Acar H, Koyu R. Assessment of tumor necrosis with Tc-99m sestamibi. European Association of Nuclear Medicine (EANM) Annual Meeting 1994, Germany. Eur J Nucl Med 1994; 21: 863. 18. Aktolun C, Yussov WY, Arka A, Glass D, Gunasekara RD, Peters AM. Exploiting granulocyte margination in the bone marrow for the diagnosis of chronic bone infection by double labelling of the granulocytes. European Association of Nuclear Medicine (EANM) Annual Meeting 1994, Germany. Eur J Nucl Med 1994; 21: 801. 19. Ussov WY, Aktolun C, Peters AM. Comparative kinetics of In-111 and Tc-99m HMPAO labelled granulocytes. British Nuclear Medicine Society Autumn Meeting 1994, England, U.K. Nucl Med Commun 1994; 15: 1001. 20. Aktolun C, Ussov WY, Arka A, Glass D, Gunasekara RD, Peters AM. Double labelled granulocytes for the diagnosis of osteomyelitis. British Nuclear Medicine Society Autumn Meeting 1994, England, U.K. Nucl Med Commun 1994; 15: 231. 21. Aktolun C, Yussov WY, Arka A, Glass D, Gunasekara RD, Peters AM. Double labelling of granulocytes for prosthetic hip infection. Society of Nuclear Medicine Annual Meeting 1994, Canada). J Nucl Med 1994; 35: 172P. 22. Aktolun C, Ussov WY, Arka A, Peters AM. Use of double isotope labelled granulocytes in the diagnosis of osteomyelitis. British Nuclear Medicine Society Autumn Meeting 1993, England, U.K. Nucl Med Commun 194; 15: 200. 23. Aktolun C, Bayhan H. Is a Tc-99m scan sufficient for the diagnosis of lingual ectopia of the thyroid? British Nuclear Medicine Society Autumn Meeting 1993, England, U.K. Nucl Med Commun 194; 15: 296. 24. Aktolun C, Bayhan H. Demonstration of pulmonary sarcoidosis with Tc-99m MIBI SPECT: comparison to Ga-67 imaging. European Association of Nuclear Medicine (EANM) Annual Meeting 1993, Switzerland. Eur J Nucl Med 1993; 20: 944. 25. Aktolun C, Yussov WY, Arka A, Glass D, Peters AM. Bone marrow marginates radiolabelled granulocytes and so need not be separately imaged for the diagnosis of osteomyelitis. European Association of Nuclear Medicine (EANM) Annual Meeting 1993, Switzerland. Eur J Nucl Med 1993; 20: 941, 944. (Nominated for Marie-Currie Award in final 5). 26. Aktolun C, Bayhan H, Kir MK, Bilgic H. Evaluation of Tc-99m-MIBI for localizing untreated primary lung carcinoma: a clinical study. British Nuclear Medicine Society Annual Meeting 1992, England, U.K. Nucl Med Commun 1992; 13: 219. (Congress Highlights Lecture). 27. Aktolun C, Bayhan H, Kir MK, Ozturk E, Gunalp B, Ayrim A. Tc-99m MIBI and Tl-201 uptake in retinoblastoma metastases. British Nuclear Medicine Society Annual Meeting 1992, England, U.K. Nucl Med Commun 1992; 13: 248. 28. Aktolun C, Bayhan H, Kir MK, Acar H. Demonstration of metastatic brain tumor with Tc-99m MIBI SPECT. British Nuclear Medicine Society Annual Meeting 1992, England, U.K. Nucl Med Commun 1992; 13: 249. (Congress Highlights Lecture). 29. Gunalp B, Ercenk B, Bayhan H, Gur E, Ozturk E, Aktolun C. Role of bone scanning in the management of non-united fractures: a clinical study. European Association of Nuclear Medicine (EANM) Annual Meeting 1991, Austria. Eur J Nucl Med 1991; 18: 549. 30. Ozturk E, Bircan Z, Buyan N, Bayhan H, Hasanoglu E, Aktolun C, Gunalp B. Can we use Tc-99m DMSA scintigraphy as a primary criteria in differentiation of acute upper and lower urinary tract infection in children? European Association of Nuclear Medicine (EANM) Annual Meeting 1991, Austria. Eur J Nucl Med 1991; 18: 561. 31. Bayhan H, Aktolun C, Kir KM, et al. Tc-99m MIBI imaging in patients with intrathoracic malignant tumors. European Association of Nuclear Medicine (EANM) Annual Meeting 1991, Austria. Eur J Nucl Med 1991; 18: 675. 32. Bayhan H, Narin Y, Ozguven MA, Aktolun C. The value of Tc-99m RBC blood pool SPECT in the detection of cavernous hemangiomas compared with planar colloid liver scanning, US, X-ray CT and angiography. European Association of Nuclear Medicine (EANM) Annual Meeting 1990, Netherlands. Eur J Nucl Med 1990; 16: 478. Hakemli Ulusal Bilimsel Kongrelerde Sunulmuş Kongre Sunumları (Papers Presented in National Scientific Congresses) 1. Demir H, Berk F, Isgören S, Özmen C, Aktolun C. The comparison of femoral neck and lumbar spine bone mineral density measurements in patients with suspected osteoporosis. Turk J Nucl Med, 2000, 9, 3:126 (The VII Asia and Oceania Congress of Nuclear Medicine & Biology & The VI International Congress of Nuclear Oncology 2000-Turkey) 2. Ural D, Ural E, Vural A, Gündoğdu T, Caymaz O, Aktolun C, Komsuoglu B. Esansiyel Hipertansiyonlu hastalarda supraventriküler aritmiler. XV. Ulusal Kardiyoloji Kongresi, 1999, İzmir. (National Cardiology Congress 1999 Abstract Book, Abstract number 228). 3. Ural D, Ural E, Vural A, Ağaçdiken A, Caymaz O, Aktolun C, Komsuoglu B. Myokard Perfüzyon defekti olan normal koroner arterli hipertansif hastaların klinik özellikleri. XV. Ulusal Kardiyoloji Kongresi, 1999, İzmir. (National Cardiology Congress 1999 Abstract Book, Abstract Number 245). 4. Ural D, Komsuoglu B, Caymaz O, Sarıkaya A, Sekban A, Aktolun C. Esansiyel hipertansiyonlu hastalarda valsalva manevrasının diyastolik doluş indekslerine etkisi. XIV. Ulusal Kardiyoloji Kongresi, 1998, Antalya. (National Cardiology Congress 1999 Abstract Book, Abstract Number 130). Diğer Yayınlar (Other Publications) 1.Uluslarası İngilizce Tıp Kitabı Eleştirisi (Book Reviews Published in International Journals) Aktolun C. ‘’Clinical Practice of Nuclear Medicine’’ (Taylor A and Datz FL published by Churchill Livingstone Inc. New York. 1991), Br J Radiol 66: 280-281, 1993. 2. Tezler (Theses) 1. Yüksek Lisans Tezi: Aktolun C. Demonstration of granulocyte margination in the bone marrow and use of double isotope labelled granulocytes for the diagnosis of osteomyelitis. A Master of Science thesis submitted to University of London, 1993, London, England, U.K. 2. Tıpta Uzmanlık Tezi: Aktolun C. Tl-201 Myokard Perfüzyon SPECT Bull'seye Sonuçlarının Yorumlanmasında Yeni Bir Yöntem ve Selektif Koroner Anjiografiyle Karşılaştırma. Gülhane Tıp Akademisi, 1990, Ankara.
Randevu al

Hizmetler

    Diğer Hizmetler

    Halil Sezai Erkut Caddesi, Ankara

    Ankara Etlik Şehir Hastanesi

    Halil Sezai Erkut Caddesi, Ankara

    Ankara Etlik Şehir Hastanesi

Adres

Haritayı büyüt yeni bir sekmede açılır
Ankara Etlik Şehir Hastanesi

Halil Sezai Erkut Caddesi, Yenimahalle, Ankara

Uygunluk

Bu adres için online randevu takvimi mevcut değil

Kabul edilen hasta/danışanlar

  • Sigortasız hastalar
Haritayı büyüt yeni bir sekmede açılır

Adres bilgileri

Kabul edilen hasta/danışanlar
  • Yetişkin
İlgili hizmetleri arayın

Hizmetler

Ankara Etlik Şehir Hastanesi

Görüşler yakında geliyor

İlk görüşü yazın

Prof. Dr. Cumali Aktolun adlı sağlık profesyonelini ziyaret ettiniz mi? Ne düşündüğünüzü paylaşarak, diğer insanlara yardımcı olabilirsiniz.

Görüş ekle

Sıkça Sorulan Sorular

Ankara civarındaki ilçelerden bazıları
Yakın zamanda aranan bazı hastalıklar
Sık kullanılan sigortalar

Payment for your appointment is required

Your specialist requests the payment of the appointment you have booked. To reschedule the appointment, please make the payment in advance or contact your specialist directly.
Ziyaretlerim Pay